PARC is an EU-wide research and innovation partnership programme to support EU and national chemical risk assessment and risk management bodies with new data, knowledge, methods, networks and skills to address current, emerging and novel chemical safety challenges. PARC will facilitate the transition to next generation risk assessment to better protect human health and the environment, in line with the Green Deal?s zero-pollution ambition for a toxic free environment and will be an enabler for the future EU ?Chemicals Strategy for Sustainability?. It builds in part on the work undertaken and experience acquired in past and on-going research and innovation actions, but goes beyond by its vocation to establish an EU-wide risk assessment hub of excellence. To contribute to several expected impacts of destination 2 ?Living and working in a health-promoting environment?, PARC will organise the activities to reach three specific objectives: - An EU-wide sustainable cross-disciplinary network to identify and agree on research and innovation needs and to support research uptake into regulatory chemical risk assessment. - Joint EU research and innovation activities responding to identified priorities in support of current regulatory risk assessment processes for chemical substances and to emerging challenges. - Strengthening existing capacities and building new transdisciplinary platforms to support chemical risk assessment. The Partnership brings together Ministries and national public health and risk assessment agencies, as well as research organisations and academia from almost all of EU Member States. Representatives of Directorates-General of the EC and EU agencies involved in the monitoring of chemicals and the assessment of risks are also participating. PARC will meet the needs of risk assessment agencies to better anticipate emerging risks and respond to the challenges and priorities of the new European policies.

RES-Q+ will build on the success of RES-Q (REgistry of Stroke Care Quality) - currently, used by many EU countries and 74 worldwide - to improve stroke care quality by collecting and analyzing hospital discharge reports. RES-Q+ will revolutionize these improvements by capturing the whole patient pathway. The solution will combine NLP with a clinically-validated semantic model to automate ingestion of hospital discharge reports in different languages and assist with audit and feedback. This will include creating a standard model for such reports and using AI to impute missing data. Further augmentations include the creation of two novel AI voice assistants, one to help patients provide feedback on their health and the other to help physicians provide high quality care. We will integrate all these tools into RES-Q+. This will be the basis for a European Open Stroke Data Platform, an open research platform for data aggregation, semantic harmonization and interoperability across European countries to promote the use and re-use of health data. We will facilitate efforts to define a standard European Stroke Hospital Discharge Report Exchange Format as a tool for better secondary use of data and healthcare in general. Consortium legal partners will develop a comprehensive legal and ethical toolbox as guidance towards legal compliance. This will boost wider adoption of such novel AI-based solutions by integrating all current and proposed Union legislation. Our clinical partners will provide medical records and steer the development to maximize clinical utility and validate final solutions. RES-Q+ will be deployed globally to solidify our position as European and global leader in quality improvement. Eventually we will guarantee citizens a similar level of quality control during hospitalizations as when flying in a commercial plane.

A structured European mechanism for COVID-19 exchange to organize and share information between countries is urgently needed, especially in the area of population health. Information on the broader impacts of COVID-19 on the health of populations is needed to facilitate multidisciplinary European research and underpin decision making. PHIRI aims to facilitate and support open, interconnected, and data-driven research through the sharing of cross-country COVID-19 population health information and exchange of best practices related to data collection, curation, processing, use and reuse following ELSI and FAIR principles. It has the objective: to provide a Health Information portal for COVID-19 with FAIR catalogues on health and health care data, to provide structured exchange between countries on COVID-19 best practices and expertise, and to promote interoperability and tackle health information inequalities. To this end, it builds with national nodes a Health Information portal (WP4) on data sources, population health studies, training material and courses, considering ethical and legal aspects. The portal is supported by WP7 that provides the technological substrate for the development of a federated research infrastructure. WP5 develops a consolidated framework to assess the direct and indirect impacts of COVID-19 on population wellbeing, morbidity and mortality. WP6 will look at COVID-19 impacts in specific subgroups by conducting research through use cases of immediate relevance and facilitates research by making scalable, reproducible methods available within PHIRI. WP8, the Rapid Exchange Forum, provides swift responses to research and policy questions that are raised in countries to handle the COVID-19 pandemic. WP9 gains insights in possible future health impacts of the coronavirus outbreak by modelling scenarios for national situations. This will be carried out in close collaboration with different types of actors and initiatives across Europe (WP3).